This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Merck Patent Gmbh. Active years: 2022-2024.
Company Filing History:
Years Active: 2022-2024
Title: Ilhan Celik: Innovator in Cancer Treatment
Introduction
Ilhan Celik is a prominent inventor based in Zwingenberg, Germany. He has made significant contributions to the field of medical treatments, particularly in oncology. With a total of 3 patents to his name, Celik is recognized for his innovative approaches to treating colorectal cancer and fibrotic disorders.
Latest Patents
Celik's latest patents include the development of Abituzumab for the treatment of colorectal cancer. This method involves administering the anti-alpha-v integrin antibody Abituzumab to patients suffering from Stage II-IV colorectal cancer, metastatic colorectal cancer, and left-sided colorectal cancer. The patent outlines the use of Abituzumab in combination with targeted therapy concepts and chemotherapy. Additionally, he has developed a method for treating patients with fibrosis and fibrotic disorders through the administration of an anti-αv integrin antibody, DI17E6.
Career Highlights
Ilhan Celik is currently associated with Merck Patent GmbH, where he continues to advance his research and development efforts. His work has been instrumental in creating effective treatment options for patients with serious medical conditions.
Collaborations
Celik collaborates with notable colleagues, including Yin Wu and Eileen Samy, to further enhance the impact of his inventions in the medical field.
Conclusion
Ilhan Celik's innovative contributions to cancer treatment and fibrotic disorders highlight his dedication to improving patient outcomes. His work at Merck Patent GmbH and his patented inventions are paving the way for advancements in medical therapies.